Deliberate Ventures Company Profile

Background

Deliberate Ventures, established in 2018 by Caen Contee, is a venture capital firm headquartered in San Francisco, California. The firm is dedicated to addressing significant global challenges by investing in innovative technology companies founded by passionate entrepreneurs, referred to as "rebels with a cause." Guided by the principles of Planet, Prosperity, Purpose, and Passion, Deliberate Ventures emphasizes environmental, social, and governance (ESG) efforts, as well as diversity, equity, and inclusion (DEI), considering these integral to ethical and successful business operations on a global scale.

Key Strategic Focus

Deliberate Ventures focuses on early-stage investments, particularly at the pre-seed and seed stages, supporting ideas that are still in the passion phase and not yet products. The firm is particularly interested in software-driven business models, including Software as a Service (SaaS), marketplaces, web3, and on-demand services, across both B2B and B2C sectors. Deliberate Ventures brings deep experience in mobility, healthcare, climate, and food industries, always seeking impact at the core.

Financials and Funding

As of the latest available data, Deliberate Ventures has made 18 investments, with 14 companies currently in its portfolio and 4 exits. The firm actively seeks new investments and operates as a venture capital firm.

Pipeline Development

Deliberate Ventures collaborates with a pipeline of psychedelic and cannabinoid compound asset holders representing real treatment approaches that demonstrate clinical "proof of concept." The firm's mandate is to complete phase 2 clinical trials for compounds that will lead to downstream market adoption and traditional supply chain disruption. Deliberate Ventures continuously works with its network of partners to identify high-potential early-phase treatments for pharmaceutical pipeline collaboration and acquisition at the end of phase 2.

Technological Platform and Innovation

Deliberate Ventures invests in companies that leverage innovative technologies to address fundamental challenges in various industries. The firm is particularly interested in software-driven business models, including SaaS, marketplaces, web3, and on-demand services, across both B2B and B2C sectors. Deliberate Ventures brings deep experience in mobility, healthcare, climate, and food industries, always seeking impact at the core.

Leadership Team

Caen Contee: Founder of Deliberate Ventures, Caen established the firm in 2018 to address significant global challenges through investments in innovative technology companies.

Andrew Fisher: Partner at Deliberate Ventures, Andrew is a veteran private equity executive with over 20 years of experience in taking technology, real estate, and media assets from inception to liquidity exits. He has managed operational teams in North America, Europe, and Asia.

Harvinder Johal: Partner at Deliberate Ventures, Harv has been in the healthcare and technology sectors for over 20 years. His experience in startups and leveraging technology for scaling and monetizing opportunities has been integral to his success.

Greg Rutherford: Partner at Deliberate Ventures, Greg is a proven strategic business leader with Canadian, US, and international experience in pharmaceuticals and healthcare. He has a record of successfully optimizing product portfolios, clinical pipelines, and launching new products.

Tommy Petersen: Co-Founder & Partner at Deliberate Ventures, Tommy is a sales and network developer with a background in establishing and maturing TeliaSonera—a large mobile company in the Danish market. He has spent over three years focusing on the global psychedelic and medical cannabis market, building strong networks and distribution setups.

Leadership Changes

As of the latest available information, there have been no recent significant changes or appointments within Deliberate Ventures' leadership team.

Competitor Profile

Market Insights and Dynamics

The venture capital industry is experiencing significant growth, with increasing investments in early-stage companies across various sectors. The focus on software-driven business models, including SaaS, marketplaces, web3, and on-demand services, reflects the industry's emphasis on scalable and innovative solutions.

Competitor Analysis

Deliberate Ventures operates in a competitive landscape alongside other venture capital firms that invest in early-stage technology companies. Key competitors include firms specializing in software-driven business models and those with a focus on sectors such as mobility, healthcare, climate, and food industries.

Strategic Collaborations and Partnerships

Deliberate Ventures collaborates with a network of partners to identify high-potential early-phase treatments for pharmaceutical pipeline collaboration and acquisition at the end of phase 2. The firm also works with pharmaceutical manufacturers to address emerging high-growth opportunities not currently met by internal R&D.

Operational Insights

Deliberate Ventures' strategic focus on early-stage investments in software-driven business models positions the firm to capitalize on emerging trends and technologies. The firm's emphasis on ESG and DEI principles differentiates it in the venture capital landscape, appealing to entrepreneurs and investors who prioritize ethical and sustainable business practices.

Strategic Opportunities and Future Directions

Deliberate Ventures aims to continue investing in innovative technology companies that align with its principles of Planet, Prosperity, Purpose, and Passion. The firm seeks to expand its portfolio by identifying and supporting early-stage companies with the potential to drive positive change and achieve significant market impact.